Middle East Veterinary Vaccines Market
Market Insights on Middle East Veterinary Vaccines covering sales outlook, demand forecast & up-to-date key trends
Middle East Veterinary Vaccines Market by Vaccine, Animal & Region for 2022 to 2031
Middle East Veterinary Vaccines Market Snapshot
[192 Pages Report] The Middle East Veterinary Vaccines Market is valued at US$ 335.0 Mn in 2021 and is expected to reach US$ 533.4 Mn by 2031, reflecting a cumulative CAGR of 4.8% over the forecast period (2022-2031) according to Future Market Insights (FMI) study.
Middle East Veterinary Vaccines Market Outlook:
|
Data Points |
Market Insights |
|
Market Value 2021 |
USD 335.0 Mn |
|
Market Value 2022 |
USD 350.8 Mn |
|
Market Value 2031 |
USD 533.4 Mn |
|
Top 3 Country Share |
51.2% |
|
CAGR 2022-2031 |
4.8% |
|
Key Players |
The key players of this industry are JOVAC, Bioveta, Inc., Intervac Pvt. Ltd., Zoetis, Elanco, Merial, Merck & Co. Inc, Bayer Pharma AG, Ceva, Boehringer Ingelheim |
The need for veterinary vaccines has been gradually increasing over the past few years owing to the rise of foodborne and zoonotic diseases in Middle Eastern countries, which makes vaccination a necessity for all animals. The preventive treatment costs of these diseases are much lower when compared to the management costs, which creates a favourable growth environment for this market over the forecast period.
For instance, a biannual mass vaccination program for foot and mouth disease, for cattle is carried out in Turkey to combat this disease. The sales of veterinary vaccines in the Middle East is expected to reach U.S. $ 335.0 Mn in the year 2021.
Rising demand for processed food items around the world is fuelling the demand for effective vaccination of livestock in countries which are the major producers of these products such as Sudan, Turkey, Egypt and KSA. Increased awareness about the quality of meat that is consumed, is majorly contributing to the demand for processed meat products around the world.
Beneficial ingredients that help fight disease and promote good health are being sought, even at premium rates, which drives the demand for processed meat and in turn is helping the growth of the veterinary vaccines market in the middle eastern region. The growing sales of meat and meat products will positively impact the growth of the Middle East veterinary vaccines market over the forecast period.
Rising per capita disposable income levels are largely contributing towards the demand for processed food items. This is expected to drive the growth of veterinary vaccines in poultry and livestock segments. Growing cases of anti-microbial drug resistance in both animals and human beings is a matter of concern for all governmental authorities around the world. Thus, increasing government initiatives to adopt the use of veterinary vaccines instead of antimicrobials in farm animals as well as companion animals is expected to propel the demand for this market over the forecast period.
The live attenuated vaccines are expected to record sales worth U.S. $ 124.3 in the year 2022, which represented a cumulative market share of more than 35%. This trend is expected to continue over the forecast period which indicates many lucrative opportunities for the vaccine manufacturers in this segment.
Veterinary vaccine manufacturers are seeking collaboration at government levels or with domestic companies in the Gulf region to mass produce veterinary vaccines and tap the largely untapped market. With limited competitive intensity, the markets in the MEA region represent a lucrative opportunities for players to enter.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
4.76% |
|
H1, 2022 Projected |
4.77% |
|
H1, 2022 Outlook |
4.67% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 09 ↓ |
H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 10 BPS. However, In H1-2022, the market growth rate of Middle East veterinary vaccines is expected to fall by only 09 basis point share (BPS) when compared with H1-2021, as per FMI analysis
The reduction in the BPS values is associated with the supply chain disruptions and medicine shortage of veterinary drugs, initiated by the advent of the COVID-19 pandemic. With import process hindered during the pandemic, the market faced a backlash in terms of management of zoonotic diseases, thus proposing a decline in the BPS change.
Conversely, the development and efficacy of second and third generation vaccines in veterinary medicine have opened up avenues for human research. This factor will promote a positive impact on the market growth.
The market is highly influenced by the regulatory approvals for therapeutics and biologics, product patenting, and government funding and grants, under the impact of macro and industry factors. The market is subject to developments like collaborations with international players to increase product accessibility. The key developments in the market include the development of recombinant viral vaccines.
2016-2021 Middle East Veterinary Vaccines Demand Outlook Compared to 2022-2031 Forecast
According to Future Market Insights (FMI), the industry registered a cumulative CAGR of 4.6% over the year 2016-2021. Middle East veterinary vaccines market accounts for approx. 4.4% of the overall global veterinary vaccines market that accounts around US$ 7.7 Bn.
The need for veterinary vaccines rose over the past few years owing to the rising awareness and importance of vaccination for livestock as well as companion animals. Growing demand for processed meat products, increasing per capita income, expenditure on good quality products and increased trade of livestock animals in the Middle Eastern countries are some of the key factors which helped the industry grow and will continue to positively affect the market demand over the forecast period.
The manufacturers of veterinary vaccines are actively seeking collaborations with the governmental authorities as well as amongst themselves to enter into the emerging markets of the Middle East. Key players are expanding their business segments by launching accompanying services to strengthen their position in the market.
In September 2020, Bioveta Inc., expanded its business in Ukraine with the commission of their ELISA laboratory. Thi laboratory was built to study the antibody titres of selected diseases and post vaccination titres of cattle, poultry, pigs, dogs and rabbits.
Future Market Insights projects the Middle East veterinary vaccines market to expand at a CAGR of 4.8% by the end of 2031. The key players conducting various R&D activities and launching innovative products in the field of veterinary vaccines, participating in active collaborations to expand their market presence.
Custom-made vaccines to provide numerous opportunities for revenue generation
Custom vaccines are specifically manufactured to cater to a specific flock and they contain inactivated biological products. Custom vaccines can be used to target specific organisms which are not included in commercial vaccines. This type of vaccine helps to fine-tune the vaccination program with respect to the need of every animal.
This is a comparatively new field in terms of veterinary vaccines, which is expected to witness growing demand in the next few years. Boehringer Ingelheim is one of the key players who provide custom-made vaccine services to improve the quality of life of poultry animals.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the key opportunities for market players?
Companies acting as a one-stop shop are expected to perform better than companies that are heavily reliant on imports. Extra regulation and costs for implementing guidelines drain the operating productivity of players. In this regard, foreign drug makers who have a manufacturing presence in the region along with local players who are well-positioned to tap the market are expected to perform better.
Greater focus on innovation to avoid zoonotic diseases coupled with advancements in biotechnology is expected to create a favourable platform for the development of veterinary vaccines in high-income economies in the region such as UAE, KSA and Turkey. These techniques include next-generation sequencing, synthetic biology and systems biology, among others. Further, continued investments in multi-disciplinary vaccinology research could improve vaccine development efficiency and shorten the time-to-market for upcoming veterinary vaccines.
Various product innovations, partnerships and collaborations are some of the key growth strategies adopted by the leading players in this industry. A less competitive environment in the emerging markets of the Middle Eastern countries creates a favourable condition for these major players to tap into these market
What is the impact of the COVID-19 crisis on the market?
The COVID-19 pandemic had an equivocal impact on the veterinary vaccines market owing to a drop in demand as veterinary visits were limited and animal healthcare was shifted for treating emergency situations and severely ill animals.
Veterinary entities all across the world had urged that animal patient care to be limited to extremely sick animals and emergencies. Furthermore, the lockdowns had caused yearly check-ups and optional immunisation treatments to be rescheduled. Various significant stakeholders, on the other hand, had secured the availability of animal vaccinations, since governments across the world were taking strong efforts to assure the supply, in order to prevent zoonotic infections from entering animal populations.
For instance, Merck & Co. announced a growth of 7% in their worldwide sales of the animal health segment in 2020.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Country-wise Insights
Will Jordan remain a key market for veterinary vaccines in the Middle East?
Jordan accounted for approximately 20.1% of the total market share of Middle East veterinary vaccines in the year 2021 owing to rising incidence of food borne and zoonotic diseases and rising per capita disposable income in the region.
Additionally, the Ministry of Agriculture (MA) offers free veterinary services, both clinical and laboratory in Jordan. They offer free animal immunizations. Simultaneously, an increasing number of private veterinary clinics and pharmacies are opening, offering a variety of veterinary services and assistance.
Furthermore, mainly a few non-governmental organisations and institutes offer veterinary services and assistance in the region.
Why is Turkey the second-largest market in the Middle East?
Turkey is expected to grow at a cumulative CAGR of 6.4% over the forecast period in the veterinary vaccines industry. Growing demand for processed meat products increased awareness about various foodborne and zoonotic disorders and growing demand for animal vaccination will help the industry expand in Turkey.
Category-wise Insights
What is the Middle East Veterinary Vaccines market value?
The Middle East veterinary vaccines market recorded sales worth U.S. $ 335.0 Mn in the year 2021 and is expected to reach U.S. $ 533.4 Mn by the year 2031. This market value growth reflects a cumulative CAGR of 4.8% over the forecast period (2022-2031).
Why is the demand for attenuated live vaccines increasing?
The attenuated live vaccines accounted for a 35.1% share of the total market of veterinary vaccines in the Middle East in 2021. The demand for attenuated live vaccines is expected to grow at a CAGR of 5.8% over the forecast period. By triggering a wide spectrum of immune responses, attenuated vaccines can deliver better immunity than conventional vaccinations. Furthermore, it helps to reduce the need for booster vaccinations that may be given orally and generates long-lasting and efficient immunity.
Additionally, increased demand for foot and mouth disease vaccination for cattle and other animals is one of the key drivers which will help the veterinary vaccines market expand in the Middle Eastern region.
Which animals will drive the demand for the veterinary vaccines market in the Middle East?
The livestock animals held the maximum share of 73.9% of the total veterinary vaccines market in terms of animals in 2021. Increased demand for processed meat products and making animal health a critical component of disease control are leading to increasing adoption of livestock animal vaccination in the Middle Eastern region.
Moreover, rising awareness regarding the importance of vaccines of livestock animals will drive the demand for the veterinary vaccines market in the Middle East.
Which disease indication takes up the largest share in the Middle East veterinary vaccines market?
Foot and mouth disease accounted for more than 27% of the market share of the Middle East veterinary vaccines market in 2021. Foot and mouth disease is the most commonly occurring disease among all animals. This creates lucrative opportunities for the foot and mouth disease vaccine manufacturers for growth over the forecast period. This segment is expected to project a cumulative CAGR of 5.6% over the forecast period.
How are private veterinary pharmacies driving the veterinary vaccines market?
The private veterinary pharmacies registered sales worth U.S. $ 114.6 Mn during the year 2021 and are expected to project a cumulative CAGR of 5.0% over the forecast period. Increased awareness regarding animal vaccinations, rising incidences of foot and mouth disease, and high demand for good quality processed meat are some of the factors contributing to the growth of private veterinary pharmacies in the Middle East.
Which is the fastest growing country in the Middle East veterinary vaccines market?
The veterinary vaccines market in Jordan, is the fastest growing market and is expected to expand at a cumulative CAGR of 5.6% over the forecast period and account for approx. 20.1% market share in 2021.
Competitive Landscape
Companies operating in the veterinary vaccines market are actively seeking to strengthen their position through acquisitions, and strategic partnerships. These strategies help accelerate the manufacturer’s strategy to capitalize on the market share and capture a significant share of the market. Some of the recent instances include:
In August 2020, Elanco Animal Health Inc. announced the acquisition of the animal health segment of Bayer AG.
In August 2021, Zoetis announced the acquisition of Jurox, which is a leading manufacturer of livestock and companion animal products. This acquisition was made to improve the product portfolio of the company and strengthen its position in the market.
The greater the demand for active products, the stronger the pipeline, which will lead to increased demand for the market. Leading industry players are focusing on the development and launch of various innovative products in the field of veterinary vaccines. This creates numerous opportunities for investment in the industry.
Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2022 to 2031 |
|
Historical Data Available for |
2016 to 2021 |
|
Market Analysis |
USD Million for Value. |
|
Key Countries Covered |
United Arab Emirates (UAE), Kingdom of Saudi Arabia (KSA), Turkey, Jordan, Sudan, Egypt and Rest of Middle East. |
|
Key Segments Covered |
Vaccine, Animal, Disease Indication, End-User and Countries. |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Middle East Veterinary Vaccines, by Category
By Vaccine:
- Attenuated Live Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Others
By Animal:
- Companion Animals
- Canine
- Avian
- Feline
- Livestock Animals
- Aquatic
- Bovine
- Porcine
- Small Ruminant
- Poultry
- Equine
By Disease Indication:
- Foot and Mouth Disease
- Newcastle Disease
- PPRS
- Canine Parvovirus
- Brucellosis
- Avian Influenza
- Others
By End-User
- Hospital Pharmacies
- Veterinary Clinics
- Private Veterinary Pharmacies
- Others
By Country:
- UAE
- KSA
- Turkey
- Jordan
- Sudan
- Egypt
- Rest of MEA
Frequently Asked Questions
The market is projected to reflect high demand in the forecast period with a CAGR of 4.8% owing to the declining popularity of antimicrobial agents for treating foodborne and zoonotic infections amongst animals, collaborative manufacturing efforts between key players and the governments, limited competitive intensity opening opportunities for various new manufacturers, growing number of foodborne and zoonotic diseases, high demand for processed food items, and non-existent interregional animal m
Jordan holds the largest market share of 20.1% of the total market share in this industry with a market value of U.S. $ 67.5 Mn recorded in the year 2021.
Some of the restraints that could hamper the growth of this market over the forecast period include the lack of resources for the collection of samples and questionable potency of the vaccines, lack of harmonized vaccine registration across the region and gaps in epidemiological knowledge of certain virulent veterinary diseases.
The key players of this industry are JOVAC, Bioveta, Inc., Intervac Pvt. Ltd., Zoetis, Elanco, Merial, Merck & Co. Inc., Bayer Pharma AG, Ceva, and Boehringer Ingelheim.
Table of Content
1. Executive Summary
1.1. Middle East Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Trends in Veterinary Vaccines
4. Key Success Factors
4.1. Key Vaccines USP Analysis
4.2. Key Manufacturers Promotional Strategies
4.3. Key regulations
4.4. Value Chain Analysis
4.5. PESTLE Analysis
4.6. PORTERS Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Increasing government support hearing disabilities
5.1.2. Improved economic conditions leading to increased penetration by companies
5.1.3. Rise in R&D spending
5.2. Forecast Factors - Relevance & Impact
5.2.1. Vaccine Launches
5.2.2. R&D expenditure by key players
5.2.3. Vaccine Adoption rate
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity
6. COVID-19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 Economic analysis
6.4. COVID19 and Impact Analysis
6.4.1. Revenue By Vaccine
6.4.2. Revenue By Animal
6.4.3. Revenue By Disease Indication
6.4.4. Revenue By Distribution Channel
6.4.5. Revenue By Country
6.5. 2021 Market Scenario
6.6. Recovery Scenario – Short term, Midterm and Long Term Impact
7. Middle East Veterinary Vaccines Market Volume (Units) Analysis 2016 – 2021 and Forecast, 2022 – 2031
7.1. Historical Market Volume (Units) Analysis, 2016-2021
7.2. Current and Future Market Volume (Units) Projections, 2022-2031
7.2.1. Y-o-Y Growth Trend Analysis
8. Middle East Veterinary Vaccines Market – Pricing Analysis
8.1. Country Level Pricing Analysis By Vaccine
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Middle East Average Pricing Analysis Benchmark
9. Middle East Veterinary Vaccines Market Demand (Size in US$ Mn) Analysis 2016–2021 and Forecast, 2022-2031
9.1. Historical Market Value (US$ Mn) Analysis, 2016–2021
9.2. Current and Future Market Value (US$ Mn) Projections, 2022-2031
9.3. Y-o-Y Growth Trend Analysis
10. Middle East Veterinary Vaccines Market Analysis 2016–2021 and Forecast 2022-2031, by Vaccine
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) By Vaccine, 2016–2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Vaccine, 2022-2031
10.3.1. Attenuated Live Vaccines
10.3.2. Inactivated Vaccines
10.3.3. Toxoid Vaccines
10.3.4. DNA Vaccines
10.3.5. Recombinant Vaccines
10.3.6. Others
10.4. Market Attractiveness Analysis By Vaccine
11. Middle East Veterinary Vaccines Market Analysis 2016–2021 and Forecast 2022-2031, by Animal
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Animal, 2016–2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Animal, 2022-2031
11.3.1. Companion Animals
11.3.1.1. Canine
11.3.1.2. Avian
11.3.1.3. Feline
11.3.2. Livestock Animals
11.3.2.1. Aquatic
11.3.2.2. Bovine
11.3.2.3. Porcine
11.3.2.4. Small Ruminant
11.3.2.5. Poultry
11.3.3. Equine
11.4. Market Attractiveness Analysis By Animal
12. Middle East Veterinary Vaccines Market Analysis 2016–2021 and Forecast 2022-2031, by Disease Indication
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Disease Indication, 2016 - 2021
12.3. Current Market Size (US$ Mn) Analysis and Forecast By Disease Indication, 2022 - 2031
12.3.1. Foot and Mouth Disease
12.3.2. New Castle Disease
12.3.3. PPRS
12.3.4. Canine Parvovirus
12.3.5. Brucellosis
12.3.6. Avian Influenza
12.3.7. Others
12.4. Market Attractiveness Analysis By Disease Indication
13. Middle East Veterinary Vaccines Market Analysis 2016–2021 and Forecast 2022-2031, by Distribution Channel
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2016 - 2021
13.3. Current Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2031
13.3.1. Hospital Pharmacies
13.3.2. Veterinary Clinics
13.3.3. Private Veterinary Pharmacies
13.3.4. Others
13.4. Market Attractiveness Analysis By Distribution Channel
14. Middle East Veterinary Vaccines Market Analysis 2016–2021 and Forecast 2022-2031, by Country
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2021
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2031
14.3.1. UAE
14.3.2. KSA
14.3.3. Turkey
14.3.4. Jordan
14.3.5. Sudan
14.3.6. Egypt
14.3.7. Rest of MEA
14.4. Market Attractiveness Analysis
15. United Arab Emirates (UAE) Veterinary Vaccines Value (in $ Mn) and Volume (000’ Units) Analysis 2016–2021 and Forecast 2022-2031
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016 - 2021
15.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2031
15.4.1. By Vaccine
15.4.2. By Animal
15.4.3. By Disease Indication
15.4.4. By Distribution Channel
15.5. Market Attractiveness Analysis
15.5.1. By Vaccine
15.5.2. By Animal
15.5.3. By Disease Indication
15.5.4. By Distribution Channel
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
16. Kingdom of Saudi Arabia (KSA) Veterinary Vaccines Value (in $ Mn) and Volume (000’ Units) Analysis 2016–2021 and Forecast 2022-2031
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016 - 2021
16.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2031
16.4.1. By Vaccine
16.4.2. By Animal
16.4.3. By Disease Indication
16.4.4. By Distribution Channel
16.5. Market Attractiveness Analysis
16.5.1. By Vaccine
16.5.2. By Animal
16.5.3. By Disease Indication
16.5.4. By Distribution Channel
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
17. Turkey Veterinary Vaccines Value (in $ Mn) and Volume (000’ Units) Analysis 2016–2021 and Forecast 2022-2031
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016 - 2021
17.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2031
17.4.1. By Vaccine
17.4.2. By Animal
17.4.3. By Disease Indication
17.4.4. By Distribution Channel
17.5. Market Attractiveness Analysis
17.5.1. By Vaccine
17.5.2. By Animal
17.5.3. By Disease Indication
17.5.4. By Distribution Channel
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
18. Jordan Veterinary Vaccines Value (in $ Mn) and Volume (000’ Units) Analysis 2016–2021 and Forecast 2022-2031
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016 - 2021
18.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2031
18.4.1. By Vaccine
18.4.2. By Animal
18.4.3. By Disease Indication
18.4.4. By Distribution Channel
18.5. Market Attractiveness Analysis
18.5.1. By Vaccine
18.5.2. By Animal
18.5.3. By Disease Indication
18.5.4. By Distribution Channel
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
19. Sudan Veterinary Vaccines Value (in $ Mn) and Volume (000’ Units) Analysis 2016–2021 and Forecast 2022-2031
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016 - 2021
19.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2031
19.4.1. By Vaccine
19.4.2. By Animal
19.4.3. By Disease Indication
19.4.4. By Distribution Channel
19.5. Market Attractiveness Analysis
19.5.1. By Vaccine
19.5.2. By Animal
19.5.3. By Disease Indication
19.5.4. By Distribution Channel
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
20. Egypt Veterinary Vaccines Value (in $ Mn) and Volume (000’ Units) Analysis 2016–2021 and Forecast 2022-2031
20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016 - 2021
20.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2031
20.4.1. By Vaccine
20.4.2. By Animal
20.4.3. By Disease Indication
20.4.4. By Distribution Channel
20.5. Market Attractiveness Analysis
20.5.1. By Vaccine
20.5.2. By Animal
20.5.3. By Disease Indication
20.5.4. By Distribution Channel
20.6. Key Market Participants - Intensity Mapping
20.7. Drivers and Restraints - Impact Analysis
21. Rest of Middle East Veterinary Vaccines Value (in $ Mn) and Volume (000’ Units) Analysis 2016–2021 and Forecast 2022-2031
21.1. Introduction
21.2. Pricing Analysis
21.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016 - 2021
21.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2031
21.4.1. By Vaccine
21.4.2. By Animal
21.4.3. By Disease Indication
21.4.4. By Distribution Channel
21.5. Market Attractiveness Analysis
21.5.1. By Vaccine
21.5.2. By Animal
21.5.3. By Disease Indication
21.5.4. By Distribution Channel
21.6. Key Market Participants - Intensity Mapping
21.7. Drivers and Restraints - Impact Analysis
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies
22.2. Market Concentration
22.3. Market Share Analysis of Top Players
22.4. Market Presence Analysis
22.4.1. By Country Level footprint of Players
22.4.2. Vaccine foot print by Players
22.4.3. Channel Foot Print by Players
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Competition Deep Dive
23.3.1. Jovac
23.3.1.1. Overview
23.3.1.2. Vaccine Portfolio
23.3.1.3. Profitability by Market Segments (Vaccine/Channel/Country)
23.3.1.4. Sales Footprint
23.3.1.5. Strategy Overview
23.3.2. Bioveta, Inc.
23.3.2.1. Overview
23.3.2.2. Vaccine Portfolio
23.3.2.3. Profitability by Market Segments (Vaccine/Channel/Country)
23.3.2.4. Sales Footprint
23.3.2.5. Strategy Overview
23.3.3. Intervac Pvt. Ltd.
23.3.3.1. Overview
23.3.3.2. Vaccine Portfolio
23.3.3.3. Profitability by Market Segments (Vaccine/Channel/Country)
23.3.3.4. Sales Footprint
23.3.3.5. Strategy Overview
23.3.4. Zoetis
23.3.4.1. Overview
23.3.4.2. Vaccine Portfolio
23.3.4.3. Profitability by Market Segments (Vaccine/Channel/Country)
23.3.4.4. Sales Footprint
23.3.4.5. Strategy Overview
23.3.5. Elanco
23.3.5.1. Overview
23.3.5.2. Vaccine Portfolio
23.3.5.3. Profitability by Market Segments (Vaccine/Channel/Country)
23.3.5.4. Sales Footprint
23.3.5.5. Strategy Overview
23.3.6. Merial
23.3.6.1. Overview
23.3.6.2. Vaccine Portfolio
23.3.6.3. Profitability by Market Segments (Vaccine/Channel/Country)
23.3.6.4. Sales Footprint
23.3.6.5. Strategy Overview
23.3.7. Merck & Co. Inc
23.3.7.1. Overview
23.3.7.2. Vaccine Portfolio
23.3.7.3. Profitability by Market Segments (Vaccine/Channel/Country)
23.3.7.4. Sales Footprint
23.3.7.5. Strategy Overview
23.3.8. Bayer Pharma AG
23.3.8.1. Overview
23.3.8.2. Vaccine Portfolio
23.3.8.3. Profitability by Market Segments (Vaccine/Channel/Country)
23.3.8.4. Sales Footprint
23.3.8.5. Strategy Overview
23.3.9. Ceva
23.3.9.1. Overview
23.3.9.2. Vaccine Portfolio
23.3.9.3. Profitability by Market Segments (Vaccine/Channel/Country)
23.3.9.4. Sales Footprint
23.3.9.5. Strategy Overview
23.3.10. Boehringer Ingelheim
23.3.10.1. Overview
23.3.10.2. Vaccine Portfolio
23.3.10.3. Profitability by Market Segments (Vaccine/Channel/Country)
23.3.10.4. Sales Footprint
23.3.10.5. Strategy Overview
24. Assumptions and Acronyms Used
25. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine
Table 02: Middle East Veterinary Vaccines Market Volume (Units) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine
Table 03: Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Animal
Table 04: Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Disease Indication
Table 05: Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By End User
Table 06: Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country
Table 07: Middle East Veterinary Vaccines Market Volume (Units) Analysis 2016-2021 and Forecast 2022-2031, By Country
Table 08: UAE Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine
Table 09: UAE Veterinary Vaccines Market Volume (Units) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine
Table 10: UAE Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Animal
Table 11: UAE Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Disease Indication
Table 12: UAE Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By End User
Table 13: KSA Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine
Table 14: KSA Veterinary Vaccines Market Volume (Units) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine
Table 15: KSA Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Animal
Table 16: KSA Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Disease Indication
Table 17: KSA Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By End User
Table 18: Turkey Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine
Table 19: Turkey Veterinary Vaccines Market Volume (Units) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine
Table 20: Turkey Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Animal
Table 21: Turkey Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Disease Indication
Table 22: Turkey Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By End User
Table 23: Jordan Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine
Table 24: Jordan Veterinary Vaccines Market Volume (Units) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine
Table 25: Jordan Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Animal
Table 26: Jordan Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Disease Indication
Table 27: Jordan Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By End User
Table 28: Sudan Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine
Table 29: Sudan Veterinary Vaccines Market Volume (Units) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine
Table 30: Sudan Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Animal
Table 31: Sudan Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Disease Indication
Table 32: Sudan Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By End User
Table 33: Egypt Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine
Table 34: Egypt Veterinary Vaccines Market Volume (Units) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine
Table 35: Egypt Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Animal
Table 36: Egypt Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Disease Indication
Table 37: Egypt Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By End User
Table 38: Rest of Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine
Table 39: Rest of Middle East Veterinary Vaccines Market Volume (Units) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine
Table 40: Rest of Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Animal
Table 41: Rest of Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Disease Indication
Table 42: Rest of Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Middle East Veterinary Vaccines Market Revenue Share by Vaccine, 2022E & 2031F
Figure 02: Middle East Veterinary Vaccines Market Revenue Share by Animal, 2022E & 2031F
Figure 03: Middle East Veterinary Vaccines Market Revenue Share by Disease Indication, 2022E & 2031F
Figure 04: Middle Veterinary Vaccines Market Revenue Share by End User, 2022E & 2031F
Figure 05: Middle East Veterinary Vaccines Market Volume Analysis, 2016-2021
Figure 06: Middle East Veterinary Vaccines Market Volume & Y-o-Y Growth (%) Analysis, 2022-2031
Figure 07: Middle East Average Pricing Analysis (US$) for Veterinary Vaccines Market (2021)
Figure 08: Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis, 2016-2021
Figure 09: Middle East Veterinary Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022-2031
Figure 10: Middle East Veterinary Vaccines Market Absolute $ Opportunity Analysis, 2022-2031
Figure 11: Middle East Veterinary Vaccines Market Analysis by Vaccine, 2022 & 2031
Figure 12: Middle East Veterinary Vaccines Market Y-o-Y Growth Projections by Vaccine, 2022-2031
Figure 13: Middle East Veterinary Vaccines Market Attractiveness, By Vaccine, 2022-2031
Figure 14: Middle East Veterinary Vaccines Market Analysis by Animal, 2022 & 2031
Figure 15: Middle East Veterinary Vaccines Market Y-o-Y Growth Projections by Animal, 2022-2031
Figure 16: Middle East Veterinary Vaccines Market Attractiveness, By Animal, 2022-2031
Figure 17: Middle East Veterinary Vaccines Market Analysis by Disease Indication, 2022 & 2031
Figure 18: Middle East Veterinary Vaccines Market Y-o-Y Growth Projections by Disease Indication, 2022-2031
Figure 19: Middle East Veterinary Vaccines Market Attractiveness, By Disease Indication, 2022-2031
Figure 20: Middle East Veterinary Vaccines Market Analysis by End User, 2022 & 2031
Figure 21: Middle East Veterinary Vaccines Market Y-o-Y Growth Projections by End User, 2022-2031
Figure 22: Middle East Veterinary Vaccines Market Attractiveness, By End User, 2022-2031
Figure 23: Middle East Veterinary Vaccines Market Analysis by Country, 2022 & 2031
Figure 24: Middle East Veterinary Vaccines Market Y-o-Y Growth Projections by Country, 2022-2031
Figure 25: Middle East Veterinary Vaccines Market Attractiveness, By Country, 2022-2031
Figure 26: UAE Veterinary Vaccines Market Size (US$ Mn) Analysis, 2016-2021
Figure 27: UAE Veterinary Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2031
Figure 28: UAE Veterinary Vaccines Market Share, By Vaccine (2022)
Figure 29: UAE Veterinary Vaccines Market Share, By Animal (2022)
Figure 30: UAE Veterinary Vaccines Market Share, By Disease Indication (2022)
Figure 31: UAE Veterinary Vaccines Market Share, By End User (2022)
Figure 32: UAE Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Vaccine
Figure 33: UAE Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Animal
Figure 34: UAE Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Disease Indication
Figure 35: UAE Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by End User
Figure 36: KSA Veterinary Vaccines Market Size (US$ Mn) Analysis, 2016-2021
Figure 37: KSA Veterinary Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2031
Figure 38: KSA Veterinary Vaccines Market Share, By Vaccine (2022)
Figure 39: KSA Veterinary Vaccines Market Share, By Animal (2022)
Figure 40: KSA Veterinary Vaccines Market Share, By Disease Indication (2022)
Figure 41: KSA Veterinary Vaccines Market Share, By End User (2022)
Figure 42: KSA Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Vaccine
Figure 43: KSA Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Animal
Figure 44: KSA Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Disease Indication
Figure 45: KSA Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by End User
Figure 46: Turkey Veterinary Vaccines Market Size (US$ Mn) Analysis, 2016-2021
Figure 47: Turkey Veterinary Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2031
Figure 48: Turkey Veterinary Vaccines Market Share, By Vaccine (2022)
Figure 49: Turkey Veterinary Vaccines Market Share, By Animal (2022)
Figure 50: Turkey Veterinary Vaccines Market Share, By Disease Indication (2022)
Figure 51: Turkey Veterinary Vaccines Market Share, By End User (2022)
Figure 52: Turkey Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Vaccine
Figure 53: Turkey Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Animal
Figure 54: Turkey Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Disease Indication
Figure 55: Turkey Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by End User
Figure 56: Jordan Veterinary Vaccines Market Size (US$ Mn) Analysis, 2016-2021
Figure 57: Jordan Veterinary Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2031
Figure 58: Jordan Veterinary Vaccines Market Share, By Vaccine (2022)
Figure 59: Jordan Veterinary Vaccines Market Share, By Animal (2022)
Figure 60: Jordan Veterinary Vaccines Market Share, By Disease Indication (2022)
Figure 61: Jordan Veterinary Vaccines Market Share, By End User (2022)
Figure 62: Jordan Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Vaccine
Figure 63: Jordan Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Animal
Figure 64: Jordan Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Disease Indication
Figure 65: Jordan Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by End User
Figure 66: Sudan Veterinary Vaccines Market Size (US$ Mn) Analysis, 2016-2021
Figure 67: Sudan Veterinary Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2031
Figure 68: Sudan Veterinary Vaccines Market Share, By Vaccine (2022)
Figure 69: Sudan Veterinary Vaccines Market Share, By Animal (2022)
Figure 70: Sudan Veterinary Vaccines Market Share, By Disease Indication (2022)
Figure 71: Sudan Veterinary Vaccines Market Share, By End User (2022)
Figure 72: Sudan Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Vaccine
Figure 73: Sudan Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Animal
Figure 74: Sudan Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Disease Indication
Figure 75: Sudan Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by End User
Figure 76: Egypt Veterinary Vaccines Market Size (US$ Mn) Analysis, 2016-2021
Figure 77: Egypt Veterinary Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2031
Figure 78: Egypt Veterinary Vaccines Market Share, By Vaccine (2022)
Figure 79: Egypt Veterinary Vaccines Market Share, By Animal (2022)
Figure 80: Egypt Veterinary Vaccines Market Share, By Disease Indication (2022)
Figure 81: Egypt Veterinary Vaccines Market Share, By End User (2022)
Figure 82: Egypt Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Vaccine
Figure 83: Egypt Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Animal
Figure 84: Egypt Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Disease Indication
Figure 85: Egypt Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by End User
Figure 86: Rest of Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis, 2016-2021
Figure 87: Rest of Middle East Veterinary Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2031
Figure 88: Rest of Middle East Veterinary Vaccines Market Share, By Vaccine (2022)
Figure 89: Rest of Middle East Veterinary Vaccines Market Share, By Animal (2022)
Figure 90: Rest of Middle East Veterinary Vaccines Market Share, By Disease Indication (2022)
Figure 91: Rest of Middle East Veterinary Vaccines Market Share, By End User (2022)
Figure 92: Rest of Middle East Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Vaccine
Figure 93: Rest of Middle East Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Animal
Figure 94: Rest of Middle East Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Disease Indication
Figure 95: Rest of Middle East Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by End User
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
